VYNT

Vyant Bio, Inc. Common Stock
VYNT

Overview Fund Activity
Delisted

VYNT was delisted on the 12th of May, 2023.

Back to rankings

23 hedge funds and large institutions have $3.66M invested in Vyant Bio, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 5 closing their positions.

Holders
23
Holders Change
-3
Holders Change %
-11.54%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$523K
2
PAM
2
Panagora Asset Management
Massachusetts
$39K
3
PCM
3
Perkins Capital Management
Minnesota
$894K
4
GIM
4
Granahan Investment Management
Massachusetts
$246K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$95K

Top Sellers

1
SCM
1
Stonepine Capital Management
Oregon
$1.24M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$216K
3
VF
3
Virtu Financial
New York
$0
4
UBS Group
4
UBS Group
Switzerland
$7K
5
HF
5
HRT Financial
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SIM
26
Spark Investment Management
New York
– – -11,600 Closed
TDC
27
Thompson Davis & Co
Virginia
$0 500 – –
Barclays
28
Barclays
United Kingdom
$0 454 – –
1
2